Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aminophylline for Recovery in FESS Under Dexmedetomidine
NCT05738135Completed
- Sponsor
- Tanta University
- Start
- Feb 2023
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of aminophylline in chronic rhinosinusitis (CRS) (2 arms), sponsored by Tanta University. Primary endpoint: Time to extubation. Started Feb 2023; status: completed.
02
Drugs
aminophylline
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT05738135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05738135.